How 48 doctors think about active surveillance

Many patients, prostate cancer advocates, and prostate cancer educators may be interested in a recent article exploring how physicians who manage prostate cancer regularly think about active surveillance (AS) and how to discuss this with their patients. … READ MORE …

Active surveillance in Oz: a situation report

An interesting article published a couple of week’s ago in the Medical Journal of Australia reports on “real world issues” related to the implementation of active surveillance (AS) in Oz. … READ MORE …

VTP in the focal therapy of low-risk, localized prostate cancer

We have previously reported data from the 2-year follow-up of the patients participating in the PCM301 trial of vascular targeted phototherapy (VTP) — a form of prostate hemiablation — compared to active surveillance in the treatment of low-risk, localized prostate cancer. New data at 4 years of follow-up have now been published in the Journal of Urology. … READ MORE …

Initial results of the MEAL trial in men on active surveillance

At the annual meeting of the American Urological Association early this morning in San Francisco, we we given the initial report on the results of the Men’s Eating and Living (MEAL) trial. … READ MORE …

Immunotherapy for men on active surveillance?

So one of the more interesting things to be announced since your sitemaster arrived at the annual meeting of the American Urological Association (AUA) in San Francisco yesterday was this one: … READ MORE …

Wide uptake of active surveillance across VA medical system

A research letter in the Journal of the American Medical Association reports a major uptake in the application of active surveillance as a first-line form of management of prostate cancer across the Veterans Affairs health system here in the US since 2005. … READ MORE …

“Getting off biopsy train in prostate cancer”

“Getting off biopsy train in prostate cancer” is the title of the latest article by Howard Wolinsky (a long-time active active surveillance patient) on the MedPage Today web site. We recommend it to your attention. … READ MORE …